These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 19816787)
1. Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias. Sauer SW; Opp S; Haarmann A; Okun JG; Kölker S; Morath MA J Inherit Metab Dis; 2009 Dec; 32(6):720-727. PubMed ID: 19816787 [TBL] [Abstract][Full Text] [Related]
2. Effect of hydroxycobalamin[c-lactam] on propionate and carnitine metabolism in the rat. Brass EP; Allen RH; Ruff LJ; Stabler SP Biochem J; 1990 Mar; 266(3):809-15. PubMed ID: 2327967 [TBL] [Abstract][Full Text] [Related]
3. 'Classical' organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. Dionisi-Vici C; Deodato F; Röschinger W; Rhead W; Wilcken B J Inherit Metab Dis; 2006; 29(2-3):383-9. PubMed ID: 16763906 [TBL] [Abstract][Full Text] [Related]
4. Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. Krahenbuhl S; Chang M; Brass EP; Hoppel CL J Biol Chem; 1991 Nov; 266(31):20998-1003. PubMed ID: 1657942 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes. Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238 [TBL] [Abstract][Full Text] [Related]
6. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. Zsengellér ZK; Aljinovic N; Teot LA; Korson M; Rodig N; Sloan JL; Venditti CP; Berry GT; Rosen S Pediatr Nephrol; 2014 Nov; 29(11):2139-46. PubMed ID: 24865477 [TBL] [Abstract][Full Text] [Related]
7. Renal involvement in a patient with cobalamin A type (cblA) methylmalonic aciduria: a 42-year follow-up. Haarmann A; Mayr M; Kölker S; Baumgartner ER; Schnierda J; Hopfer H; Devuyst O; Baumgartner MR Mol Genet Metab; 2013 Dec; 110(4):472-6. PubMed ID: 24095221 [TBL] [Abstract][Full Text] [Related]
8. Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist. Morath MA; Hörster F; Sauer SW Pediatr Nephrol; 2013 Feb; 28(2):227-35. PubMed ID: 22814947 [TBL] [Abstract][Full Text] [Related]
9. Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. Kölker S; Schwab M; Hörster F; Sauer S; Hinz A; Wolf NI; Mayatepek E; Hoffmann GF; Smeitink JA; Okun JG J Biol Chem; 2003 Nov; 278(48):47388-93. PubMed ID: 12972416 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Hörster F; Baumgartner MR; Viardot C; Suormala T; Burgard P; Fowler B; Hoffmann GF; Garbade SF; Kölker S; Baumgartner ER Pediatr Res; 2007 Aug; 62(2):225-30. PubMed ID: 17597648 [TBL] [Abstract][Full Text] [Related]